The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $38.46

Today's change-0.40 -1.02%
Updated May 3 9:47 AM EDT. Delayed by at least 15 minutes.
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $38.46

Today's change-0.40 -1.02%
Updated May 3 9:47 AM EDT. Delayed by at least 15 minutes.

Abbott Laboratories down (U.S.)$0.40

Abbott Laboratories is lower today, dropping (U.S.)$0.40 or 1.02% to (U.S.)$38.46. Over the last five days, shares have lost 12.36% and are down 14.37% for the last year to date. This security has underperformed the S&P 500 by 15.58% during the last year.

Key company metrics

  • Open(U.S.) $38.80
  • Previous close(U.S.) $38.85
  • High(U.S.) $38.83
  • Low(U.S.) $38.44
  • Bid / Ask(U.S.) $38.45 / (U.S.) $38.46
  • YTD % change-14.37%
  • Volume1,274,833
  • Average volume (10-day)14,635,613
  • Average volume (1-month)7,890,409
  • Average volume (3-month)7,795,444
  • 52-week range(U.S.) $36.00 to (U.S.) $51.74
  • Beta0.99
  • Trailing P/E27.07×
  • P/E 1 year forward17.60×
  • Forward PEG1.86×
  • Indicated annual dividend(U.S.) $1.04
  • Dividend yield2.70%
  • Trailing EPS(U.S.) $1.42
Updated May 3 9:47 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.97%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue4,8855,1885,1505,170
Total other revenue--------
Total revenue4,8855,1885,1505,170
Gross profit2,7452,9662,9412,952
Total cost of revenue2,1402,2222,2092,218
Total operating expense4,3614,3734,4374,441
Selling / general / administrative1,6981,6561,6401,727
Research & development379375338345
Depreciation / amortization144143151151
Interest expense (income), net operating--------
Unusual expense (income)---2399--
Other operating expenses, total--------
Operating income524815713729
Interest income (expense), net non-operating-25-41-41-44
Gain (loss) on sale of assets--------
Other--------
Income before tax2830714986
Income after tax56695596786
Income tax, total-54135118200
Net income316767580784
Total adjustments to net income--------
Net income before extra. items56695596786
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items56695596786
Inc. avail. to common incl. extra. items316767580784
Diluted net income316767580784
Dilution adjustment--------
Diluted weighted average shares1,4841,4971,5051,504
Diluted EPS excluding extraordinary itemsvalue per share0.040.460.400.52
Dividends per sharevalue per share0.260.260.240.24
Diluted normalized EPSvalue per share0.040.450.450.52